We are live on ! Find out more
NSPR icon

InspireMD

10 hedge funds and large institutions have $389K invested in InspireMD in 2018 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

11% more capital invested

Capital invested by funds: $351K → $389K (+$38.4K)

0% more funds holding

Funds holding: 1010 (0)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

0.02% less ownership

Funds ownership: 0.03%0.01% (-0.02%)

Holders
10
Holders Change
Holders Change %
0%
% of All Funds
0.23%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
2
Reduced
2
Closed
4
Calls
Puts
Net Calls
Net Calls Change

NSPR Hedge Fund Activity: Q3 2018 in Review

10 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in InspireMD (NSPR) for Q3 2018, worth a combined $389K — up 11% from $351K a quarter earlier.

Fund positioning in NSPR was balanced in Q3 2018: 4 funds opened new positions, 4 closed out, 2 added to existing stakes and 2 trimmed.

The largest buyer was Sabby Management, adding an estimated $94.7K. The largest seller was Anson Funds Management, exiting entirely with an estimated $92K sold.

  • 10 institutional investors held InspireMD (NSPR) as of Q3 2018, unchanged from Q2 2018.
  • Funds reported $389K of InspireMD stock for Q3 2018, up 11% quarter-over-quarter.
  • 4 funds opened new InspireMD positions in Q3 2018 and 4 closed out, a net change of 0 holders.
  • The largest InspireMD buyer in Q3 2018 was Sabby Management, an estimated $94.7K added.
  • The largest InspireMD seller in Q3 2018 was Anson Funds Management, an estimated $92K sold.

Based on aggregated 13F filings for Q3 2018.